Cancer Gene Therapy
Studies from University of Rochester, Department of Urology in the area of cancer gene therapy published
Published in Gene Therapy Weekly, May 10th, 2007
Current study results from the report, "The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3," have been published. "Insulin-like growth factor binding protein-3 (IGFBP-3) is a well-known antiproliferative and proapoptotic molecule in prostate cancer, suggesting that targeting IGFBP-3 might produce clinical benefits. In prostate cancer cells, RRR-alpha-vitamin E succinate (VES) inhibits cell proliferation and induces apoptosis, yet the mechanisms remain to be elucidated," investigators in the United States report.
"We hypothesize that the protective effects of VES in...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-05-10)
More Articles from Gene Therapy Weekly
- Gene Therapy
New treatment for fungus which causes thrush and sepsis - Gene Therapy
Stanford scientists make major breakthrough in regenerative medicine - Gene Therapy
UHN Receives Second $10 Million Gift to Support McEwen Centre for Regenerative Medicine - Lung Cancer
Ireland Cancer Center researchers advance lung cancer treatment - Cancer Gene Therapy
AMDL Management Team in China for Key Business Initiatives - Cancer Gene Therapy
Mimi Hancock, Ph.D., Joins Bionovo's Board of Directors - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
